| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$416,657 ) |
| | 2024 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 000 | 34 | NIH | 11/7/2023 | -$138,443 |
| | 2024 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM026017 | Enzymatic Mechanisms of Genetic Recombination | 000 | 45 | NIH | 1/30/2024 | -$119,966 |
| | 2024 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R35GM122476 | Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis | 000 | 5 | NIH | 4/4/2024 | -$158,247 |
|
| Issue Date FY: 2023 ( Subtotal = -$384,542 ) |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 004 | 17 | NIH | 8/29/2023 | -$1 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 002 | 4 | NIH | 7/13/2023 | -$139,484 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 4 | NIH | 4/14/2023 | $657,586 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 4 | NIH | 4/14/2023 | $139,484 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 002 | 4 | NIH | 7/13/2023 | -$657,586 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 002 | 17 | NIH | 8/4/2023 | -$144,037 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 001 | 17 | NIH | 2/14/2023 | $33,726 |
| | 2023 | 2023 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 000 | 17 | NIH | 12/14/2022 | $303,560 |
| | 2023 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 000 | 34 | NIH | 5/30/2023 | $0 |
| | 2023 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 004 | 3 | NIH | 9/15/2023 | -$420,088 |
| | 2023 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 004 | 3 | NIH | 9/15/2023 | -$89,107 |
| | 2023 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 000 | 3 | NIH | 2/11/2023 | $0 |
| | 2023 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 000 | 3 | NIH | 2/11/2023 | $0 |
| | 2023 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM026017 | Enzymatic Mechanisms of Genetic Recombination | 000 | 45 | NIH | 3/10/2023 | $0 |
| | 2023 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | K99CA252020 | Dissecting the cis-regulatory roles of transposable elements in human cancers | 000 | 2 | NIH | 10/20/2022 | -$64,958 |
| | 2023 | 2019 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | U54DK107977 | San Diego Center for 4D Nucleome Research | 000 | 5 | NIH | 3/30/2023 | -$2,959 |
| | 2023 | 2019 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | U54DK107977 | San Diego Center for 4D Nucleome Research | 001 | 5 | NIH | 3/30/2023 | -$678 |
|
| Issue Date FY: 2022 ( Subtotal = $1,638,917 ) |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 001 | 16 | NIH | 6/9/2022 | $105,683 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 001 | 34 | NIH | 6/9/2022 | $40,000 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 000 | 34 | NIH | 11/10/2021 | $360,000 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 3 | NIH | 4/1/2022 | $657,750 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 3 | NIH | 4/1/2022 | $139,519 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | K99HG011483 | Studying the mammalian regulatory circuits by developing single-cell multi-omics technologies | 001 | 2 | NIH | 6/17/2022 | -$47,225 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | K99HG011483 | Studying the mammalian regulatory circuits by developing single-cell multi-omics technologies | 002 | 2 | NIH | 9/15/2022 | -$5,990 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | K99HG011483 | Studying the mammalian regulatory circuits by developing single-cell multi-omics technologies | 000 | 2 | NIH | 11/5/2021 | $113,415 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 002 | 16 | NIH | 7/27/2022 | $33,727 |
| | 2022 | 2022 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074207 | Analysis of Centrosome Dynamics | 000 | 16 | NIH | 12/22/2021 | $303,559 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 000 | 2 | NIH | 3/18/2022 | $0 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 000 | 2 | NIH | 3/18/2022 | $0 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | K99NS114162 | Determining the molecular organization of TDP-43 in liquid spherical annuli and establishing a designer gene therapeutic strategy to degrade TDP-43 aggregates | 000 | 2 | NIH | 6/9/2022 | -$59,857 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R35GM122476 | Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis | 000 | 5 | NIH | 7/22/2022 | $0 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074215 | Kinetochore Specification and Function | 003 | 17 | NIH | 8/2/2022 | $0 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074215 | Kinetochore Specification and Function | 001 | 17 | NIH | 4/4/2022 | $0 |
| | 2022 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM074215 | Kinetochore Specification and Function | 000 | 17 | NIH | 4/4/2022 | $0 |
| | 2022 | 2019 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | F32AG059358 | Determine how loss-of-function of the TBK1 kinase causes age-dependent degeneration in frontotemporal dementia | 001 | 2 | NIH | 4/22/2022 | -$1,664 |
| | 2022 | 2018 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | F32CA210407 | The role of S. cerevisiae Mlh1-Pms1 during MMR strand discrimination | 000 | 3 | NIH | 9/23/2022 | $0 |
| | 2022 | 2018 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | F32AG059358 | Determine how loss-of-function of the TBK1 kinase causes age-dependent degeneration in frontotemporal dementia | 000 | 1 | NIH | 4/22/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,797,709 ) (Continued on the next page) |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS027036 | Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias | 000 | 34 | NIH | 7/28/2021 | $510,116 |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 001 | 33 | NIH | 2/22/2021 | $40,000 |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01GM050006 | Enzymology of Mismatch Repair in Yeast | 000 | 33 | NIH | 11/24/2020 | $360,000 |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 2 | NIH | 5/11/2021 | $0 |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 001 | 2 | NIH | 5/11/2021 | $0 |
| | 2021 | 2021 | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD | 8950 VILLA LA JOLLA DR STE C135 | LA JOLLA | CA | 92037-1703 | SAN DIEGO | USA | R01NS112503 | Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | 000 | 2 | NIH | 3/11/2021 | $658,756 |
|
